BSP IS THE STRATEGIC PARTNER FOR INNOVATORS SEEKING A CDMO WHICH PROVIDES AN INTEGRATED FULL RANGE OF SERVICES IN FULL CONTAINMENT FROM DEVELOPMENT OF A PROOF OF CONCEPT TO COMMERCIAL SUPPLY OF CYTOTOXIC AND NON CYTOTOXIC CANDIDATES IN ONCOLOGY, IMMUNONCOLOGY AND IMMUNOTHERAPHY
CYTO & HiPo
ADCs
DS & DP MANUFACTURING CAPABILITIES
- Conjugation of ADC’s
- Development (10mg - 50g)
- Clinical and Commercial (40g - 15 Kg)
ADCs AWARDS
Download Brochure
CYTO & HiPo
Sterile injectables
CAPABILITIES
- Isotechnology and Full Containment up to OEL<10ng/m3 and OEB 6
- Small and Large molecules
- Batch size from 1.000 to 50.000 vials
- 7 Filling lines to produce liquid and lyo vials
Download Brochure
Non-CYTO & HiPo
Sterile injectables
CAPABILITIES
- Isotechnology and Full Containment up to OEL<10ng/m3 and OEB 6
- Small and Large molecules
- Batch size from 1.000 to 250.000 vials
- 7 Filling lines to produce liquid and lyo vials
Download Brochure
CYTO & HiPo
Oral Solid
CAPABILITIES
- Dedicated manufacturing area for tabs, minitabs, capsules, LFHC
- Development: 100g to 1000g
- GMP Clinical and Commercial: 4Kg to 100Kg
Download Brochure
Development
CAPABILITIES
- Preformulation and formulation development
- Analytical methods Development
- Process Development: oral solids, conjugation, liquid and lyo formulations, complex formulations
- Stability studies
Download Brochure
QC
CAPABILITIES
- Analytical method transfer and validation
- Cleanability and Compatibility studies
- Incoming material testing, IPC, Final full release
- Stability and Photostability studies
Download Brochure
BSP CAMPUS AREAS
SOUTH VIEW
HEADQUARTER AND MANUFACTURING PLANT
BSP Pharmaceuticals S.p.A.
Via Appia km 65,651 04013 Latina Scalo - Italy
Phone: +39 0773 8221
Mail: info@bsppharmaceuticals.com
FOR TECHNICAL INQUIRIES AND TO REQUEST A QUOTATION
